O-2372

From Wikipedia, the free encyclopedia
Jump to: navigation, search
O-2372
O-2372 structure.png
Systematic (IUPAC) name
6-((6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-3-yl)-6-methyl-1-morpholinoheptan-1-one
Clinical data
Identifiers
 YesY
PubChem CID 24848987
ChemSpider 21259336 N
Chemical data
Formula C28H41NO4
455.629 g/mol
 N (what is this?)  (verify)

O-2372 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. It has high affinity for both CB1 and CB2 receptors, with Ki values of 1.3nM at CB1 and 0.57nM at CB2, but is only moderately soluble in water compared to other related compounds such as O-2694, which it is a metabolite of.[1]

See also[edit]

References[edit]

  1. ^ Martin BR, et al. Pharmacological characterization of novel water-soluble cannabinoids. Journal of Pharmacology and Experimental Therapeutics. 2006 Sep;318(3):1230-9. PMID 16757541